Dear investors, we continue building up the company's capitalisation.
Today we have finalised and filed for registration the documents for our new glucose measurement development.
This development secures for our company the priority right to apply the innovative membrane used in our CGM.
More details will be disclosed once the contents are published and the rights are registered.
Link to the notice of accepting the new application from the patent office: https://mail-cdn.mlc.health/patents/RU2024109890_Notification_Rospatent's_acceptance_of_the_application.pdf
Recently we have reported in the news about our plans for intellectual property registration.
Registration of our intellectual property and unique developments will become our regular news section.
You can read about it in the earlier news: https://my.mlc.health/en/site/newsinfo/2364
We will recap the main content.
We expect to register up to 20 patents in 2024 and aim to grow the registration pace each year.
Intellectual property increases MLC's capitalisation and benefits every investor.
Do you already own the shares of MLC?
A stage change is coming soon.
Hurry up to buy shares at a beneficial price!
